Company: RCUS
Filing Date: 2025-10-28
Form Type: 10-Q
Source: 0001724521-25-000116
Chunk: 192

Company: Arcus Biosciences, Inc.
Filing Date: 2025-10-28
Form: 10-Q
Item: Part II, Item 5
Chunk 192
---
Item 5. Other Information.

Rule 10b5-1 Trading Arrangements

The adoption, modification or termination of contracts, instructions or written plans for the purchase or sale of our securities by our Section 16 officers and directors for the three months ended September 30, 2025, which are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act, were as follows:Name and TitleActionDateTotal Shares to be SoldExpiration DateRobert C. Goeltz IIChief Financial OfficerAdoptionSeptember 10, 202550,138January 29, 2027Juan JaenPresidentAdoptionAugust 8, 2025265,993November 13, 2026

64